| Předmět: |
|
| Zdroj: |
Drug Week; 7/22/2024, p2528-2528, 1p |
| Abstrakt: |
A new report discusses research findings on pharmaceuticals, specifically focusing on bioequivalence studies in generic drug development. The report highlights the complexities involved in these studies and explores the use of physiologically based biopharmaceutics modeling (PBBM) for virtual bioequivalence assessment. The researchers emphasize the importance of incorporating variability and developing a virtual population for accurate bioequivalence assessment. The report also includes case studies and regulatory perspectives on virtual bioequivalence. For more information, readers can access the full article published in Pharmaceuticals. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
